Trial Profile
A Phase III Placebo-Controlled Trial Of Celecoxib In Genotype Positive Subjects With Familial Adenomatous Polyposis.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 12 Dec 2022
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Colorectal cancer; Familial adenomatous polyposis
- Focus Registrational; Therapeutic Use
- Acronyms CHIP
- Sponsors Pfizer
- 05 Jan 2021 This trial has been completed in Germany, according to European Clinical Trials Database record.
- 26 Jul 2020 This trial has been completed in United Kingdom according to European Clinical Trials Database record.
- 09 Feb 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.